NCT06633848 Establishment of Clinical Prediction Model for Postoperative Symptomatic Spinal Epidural Hematoma
| NCT ID | NCT06633848 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Third Hospital |
| Condition | Spinal Epidural Hematoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2025-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to establish a clinical prediction model based on artificial intelligence algorithms for patients with postoperative symptomatic spinal epidural hematoma(PSSEH) after spinal surgery. The investigators will collect the features of 2000 patients as the training set to train the models using AI algorithms, then recruit a prospective cohort of 2000 patients to test if the trained model is precise and consistent to predict the occurrence of PSSEH as well as to find out whether there is any new risk factor of PSSEH.
Eligibility Criteria
Inclusion Criteria: * patients who will receive spinal surgery from January 2025 to December 2026 at Peking University Third Hospital Exclusion Criteria: * patients with a history of lumbar trauma before admission; * patients who suffer from malignant tumor; * patients with systemic infection; * patients who quit the study midway
Contact & Investigator
Orthopedics Department of Peking University Third Hospital
✉ 2411210441@pku.edu.cn📞 008618811597977
Frequently Asked Questions
Who can join the NCT06633848 clinical trial?
This trial is open to participants of all sexes, studying Spinal Epidural Hematoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06633848 currently recruiting?
Yes, NCT06633848 is actively recruiting participants. Contact the research team at 2411210441@pku.edu.cn for enrollment information.
Where is the NCT06633848 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06633848 clinical trial?
NCT06633848 is sponsored by Peking University Third Hospital. The trial plans to enroll 2,000 participants.